Propionic Acid

Propionic Acid

SCHEMBL4159413

CCC(=O)O.Cn1ccc(-c2ccc3[nH]c(=O)c4[nH]ccc4c3c2)n1

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.36
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
P2RX7 Q99572 1/20 0.36
GRM5 P41594 1/20 0.35
CHEK1 O14757 1/20 0.35
PARP1 P09874 1/20 0.34
KDM4A O75164 1/20 0.34
KDM4B O94953 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
JAK1 P23458 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP19A1 P11511 1/20 0.33
ALDH1A1 P00352 1/20 0.32
PIM1 P11309 1/20 0.32
KDM4E B2RXH2 1/20 0.32
JMJD6 Q6NYC1 1/20 0.32
MALT1 Q9UDY8 1/20 0.32
TYK2 P29597 2/20 0.32
KEAP1 Q14145 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4153840 0.83 PIM1 (0.44) KMT2AALDH1A1PIM1KDM4E
Propionic Acid SCHEMBL4159513 0.83 GABRA1 (0.33) KMT2AALDH1A1PIM1KDM4E
Propionic Acid SCHEMBL4162600 0.81 PARP1 (0.38) PARP1KMT2AALDH1A1PIM1KDM4E
Propionic Acid SCHEMBL4160151 0.80 PTGS2 (0.48)
Propionic Acid SCHEMBL4155444 0.79 PARP1 (0.43) PARP1KMT2AALDH1A1PIM1KDM4E
Propionic Acid SCHEMBL4153298 0.79 PARP1 (0.45) P2RX7PARP1KMT2AALDH1A1PIM1
Propionic Acid SCHEMBL4167721 0.79 PRKAG1 (0.46) ALDH1A1KDM4EKEAP1
Propionic Acid SCHEMBL4157712 0.78 CDK2 (0.41) PIM1
Propionic Acid SCHEMBL4155220 0.78 FASN (0.41) KMT2APIM1BRD4
Propionic Acid SCHEMBL4155190 0.78 PTGS2 (0.40) PARP1ALDH1A1KDM4EBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 ADORA2A 2985/4885MKNK1 78/4885MKNK2 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.